BSX Stock Recent News
BSX LATEST HEADLINES
In the latest trading session, Boston Scientific (BSX) closed at $106.66, marking a +1.1% move from the previous day.
MARLBOROUGH, Mass. , Sept. 2, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Tuesday, September 30, 2025, beginning at 8:30 a.m.
Here is how Boston Scientific (BSX) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.
For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a slump that can lead to the firm's eventual demise.
Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.
Uber, JPMorgan and RTX are stocks to watch. The market jumped Friday as Fed chief Powell hinted at rate cuts.
BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?